(Q54261978)

26 May 2018

title

Rip2 modifies VEGF-induced signalling and vascular permeability in myocardial ischaemia. (English)

1 reference

26 May 2018

11

Jan Borén

1 reference

26 May 2018

author name string

Linda Andersson

1

1 reference

26 May 2018

Margareta Scharin Täng

2

1 reference

26 May 2018

Annika Lundqvist

3

1 reference

26 May 2018

Malin Lindbom

4

1 reference

26 May 2018

Ismena Mardani

5

1 reference

26 May 2018

Per Fogelstrand

6

1 reference

26 May 2018

Puja Shahrouki

7

1 reference

26 May 2018

Björn Redfors

8

1 reference

26 May 2018

Elmir Omerovic

9

1 reference

26 May 2018

Max Levin

10

1 reference

26 May 2018

Malin C Levin

12

1 reference

26 May 2018

publication date

30 June 2015

1 reference

26 May 2018

published in

Cardiovascular Research

1 reference

26 May 2018

volume

107

1 reference

26 May 2018

issue

4

1 reference

26 May 2018

page(s)

478-486

1 reference

26 May 2018

Pathophysiological consequences of VEGF-induced vascular permeability

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Toll-like receptor 3 plays a role in myocardial infarction and ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Involvement of receptor-interacting protein 2 in innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Rip2 deficiency leads to increased atherosclerosis despite decreased inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Fundamental role of the Rip2/caspase-1 pathway in hypoxia and ischemia-induced neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Genetic dissection of neurotrophin signaling through the p75 neurotrophin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

A dual role for receptor-interacting protein kinase 2 (RIP2) kinase activity in nucleotide-binding oligomerization domain 2 (NOD2)-dependent autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Protection against myocardial infarction and no-reflow through preservation of vascular integrity by angiopoietin-like 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Early expression of angiogenesis factors in acute myocardial ischemia and infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat--angiogenesis and angioma formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Vascular endothelial growth factor-angiopoietin chimera with improved properties for therapeutic angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Angiopoietin-1 protects heart against ischemia/reperfusion injury through VE-cadherin dephosphorylation and myocardiac integrin-β1/ERK/caspase-9 phosphorylation cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Frizzled7 controls vascular permeability through the Wnt-canonical pathway and cross-talk with endothelial cell junction complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

VEGFR2 trafficking: speed doesn't kill

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Endocytosis and signalling: intertwining molecular networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

The contribution of VEGF signalling to fostamatinib-induced blood pressure elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Pathogen-derived effectors trigger protective immunity via activation of the Rac2 enzyme and the IMD or Rip kinase signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Manipulation of small Rho GTPases is a pathogen-induced process detected by NOD1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Filamin B plays a key role in vascular endothelial growth factor-induced endothelial cell motility through its interaction with Rac-1 and Vav-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Vascular-specific growth factors and blood vessel formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

RIP2 activity in inflammatory disease and implications for novel therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

Small molecule tyrosine kinase inhibitors for the treatment of intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV186

21 January 2018

Identifiers

DOI

10.1093/CVR/CVV186

1 reference

26 May 2018

1 reference

26 May 2018